Literature DB >> 2189998

How to use prognostic factors in axillary node-negative breast cancer patients.

W L McGuire1, A K Tandon, D C Allred, G C Chamness, G M Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2189998     DOI： 10.1093/jnci/82.12.1006

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  55 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

Review 2.  The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview.

Authors:  L Liotta
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

3.  Prognostic factors and natural history in lymph node-negative breast cancer patients.

Authors:  R Arriagada; L E Rutqvist; L Skoog; H Johansson; A Kramar
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors:  T Decker; D Hungermann; W Böcker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

5.  Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells.

Authors:  A Aydiner; M Ridvanogullari; D Anil; E Topuz; R Nurten; R Disci
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.

Authors:  Jyothi S Prabhu; Kanu Wahi; Aruna Korlimarla; Marjorrie Correa; Suraj Manjunath; N Raman; B S Srinath; T S Sridhar
Journal:  Tumour Biol       Date:  2012-02-24

7.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

Authors:  S M Siitonen; O P Kallioniemi; J J Isola
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 8.  Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.

Authors:  W C Wood
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

9.  Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.

Authors:  H Schimmelpenning; E T Eriksson; U G Falkmer; E Azavedo; G Svane; G U Auer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.